NANOVACCINES
DESCRIPTION
The NOSEVAC project aims at developing and evaluating innovative nasal vaccine platforms as a novel approach to prevent the earliest stage of infection, thereby inhibiting upper respiratory tract (URT) colonisation, transmission and disease.
Under the European Vaccine Initiative (EVI) coordination, the NOSEVAC project builds on a unique consortium of 13 complementary teams from the EU, UK and Switzerland.
(https://www.nosevac-project.eu)
Share The Knowledge
CONTACT
Phone: (34) 881815454
E-Mail: mariaj.alonso@usc.es
Mailing Address:
CIMUS Research Institute
Avda. de Barcelona s/n
Campus Vida s/n
15782, Santiago de Compostela